Overview

Effect of CD07805/47 Gel in Rosacea Flushing

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Phase 2a study to assess the efficacy and safety of CD07805/47 0.5% gel in the prevention of the flush of rosacea.
Phase:
Phase 2
Details
Lead Sponsor:
Galderma R&D